Concepedia

Red blood cell distribution width as a marker of hyperinflammation and mortality in COVID-19

Víctor Moreno‐Torres, Enrique Sánchez-Chica, Raquel Castejón, Antonio F Caballero-Bermejo, Patricia Mills, Elena Diago-Sempere, Silvia Rosado, Aránzazu Sancho‐López, Juan‐Antonio Vargas‐Núñez, Belén Ruíz‐Antorán,

Annals of Palliative Medicine · 2022 · 26 citations · 25 references

DOIFull text

Open access

Abstract

RDW predicts COVID-19-associated ARDS mortality and reflects the hyperinflammatory background and the effects of cytokines such as IL-6, irrespective of tocilizumab treatment.

References

25

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 28.8K citations · Full text

, , +11

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Chaomin Wu, Yanping Cai, Jiaan Xia et al. · JAMA Internal Medicine · 2020 · 8.6K citations · Full text

Dexamethasone in Hospitalized Patients with Covid-19.

DiRROS repository (University of Maribor) · 2020 · 8K citations · Full text

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5K citations · Full text

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text